(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are INDLE FIN.ENTREPR., BENEVOLENTAI, and AFFLUENT MEDICAL.

Financial Asset	Price	Change	Updated (EST)
INDLE FIN.ENTREPR. (INFE.PA)	94.50	62.93%	2023-12-22 13:04:58
BENEVOLENTAI (BAI.AS)	0.75	36.36%	2023-12-22 12:00:52
AFFLUENT MEDICAL (AFME.PA)	2.12	15.22%	2023-12-22 12:45:05
BELYSSE GROUP (BELYS.BR)	0.74	11.78%	2023-12-22 12:05:08
NEXITY (NXI.PA)	17.26	11.07%	2023-12-22 13:20:41
MOLTEN VENTURES (GRW.IR)	3.24	10.2%	2023-12-22 12:22:54
PIERRE VAC BSA ACT (VACBS.PA)	0.17	8.68%	2023-12-22 13:21:23
OCEANTEAM (OTS.OL)	1.40	8.53%	2023-12-22 12:41:45
ARGENX SE (ARGX.BR)	320.60	7.33%	2023-12-22 12:04:47
HYLORIS (HYL.BR)	11.80	7.27%	2023-12-22 12:20:11

The three biggest losers today are PROSUS, NORTHERN DRILLING, and SOC FRANC CASINOS.

Financial Asset	Price	Change	Updated (EST)
PROSUS (PRX.AS)	24.53	-17.1%	2023-12-22 12:03:37
NORTHERN DRILLING (NODL.OL)	1.19	-10.86%	2023-12-22 12:41:35
SOC FRANC CASINOS (SFCA.PA)	1.68	-10.16%	2023-12-22 13:22:48
HOSTELWORLD GROUP (HSW.IR)	1.48	-8.64%	2023-12-22 12:22:43
GROUPE SFPI (SFPI.PA)	1.95	-8.45%	2023-12-22 13:04:31
BYGGMA (BMA.OL)	20.20	-6.05%	2023-12-22 12:25:26
SEQUANA MEDICAL (SEQUA.BR)	3.70	-5.61%	2023-12-22 12:21:27
ATEME (ATEME.PA)	6.54	-5.22%	2023-12-22 12:45:48
ATENOR (ATEB.BR)	6.20	-4.62%	2023-12-22 12:04:51
SALMAR (SALM.OL)	530.60	-4.57%	2023-12-22 12:42:38

Winners today

1. INDLE FIN.ENTREPR. (INFE.PA)

62.93% Price Change

Compagnie Industrielle et Financière d'Entreprises SA operates as a construction company in France. It undertakes maritime and river, underwater, structures and civil engineering, buildings, and other special works. The company also develops real estate properties. Compagnie Industrielle et Financière d'Entreprises SA was founded in 1913 and is headquartered in Saint-Herblain, France. The company is a subsidiary of Alfred de Musset SAS.

CAC 40 ended the session with INDLE FIN.ENTREPR. jumping 62.93% to €94.50 on Friday while CAC 40 fell 0.03% to €7,568.82.

Earnings Per Share

As for profitability, INDLE FIN.ENTREPR. has a trailing twelve months EPS of €4.78.

PE Ratio

INDLE FIN.ENTREPR. has a trailing twelve months price to earnings ratio of 19.77. Meaning, the purchaser of the share is investing €19.77 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.21%.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Jun 28, 2023, the estimated forward annual dividend rate is 2 and the estimated forward annual dividend yield is 3.39%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, INDLE FIN.ENTREPR.’s stock is considered to be overbought (>=80).

Revenue Growth

Year-on-year quarterly revenue growth grew by 27.3%, now sitting on 250.05M for the twelve trailing months.

More news about INDLE FIN.ENTREPR..

2. BENEVOLENTAI (BAI.AS)

36.36% Price Change

BenevolentAI S.A. operates as a clinical-stage AI-enabled drug discovery and development company. Its BenevolentAI platform powers in-house drug pipeline of drug programs. The company's therapeutic areas, include atopic dermatitis, ulcerative colitis, amyotrophic lateral sclerosis, glioblastoma multiforme, inflammatory bowel disease, antiviral, oncology, parkinson's disease, nonalcoholic steatohepatitis, fibrosis, inflammation, chronic kidney disease, and idiopathic pulmonary fibrosis. It has a collaboration with AstraZeneca to enhance understanding of complex disease biology and identify new targets. The company was founded in 2013 and is headquartered in London, United Kingdom.

AEX-Index ended the session with BENEVOLENTAI jumping 36.36% to €0.75 on Friday, following the last session’s upward trend. AEX-Index slid 0.56% to €785.45, following the last session’s downward trend on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, BENEVOLENTAI has a trailing twelve months EPS of €-0.47.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -40.97%.

More news about BENEVOLENTAI.

3. AFFLUENT MEDICAL (AFME.PA)

15.22% Price Change

Affluent Medical SA develops minimally invasive medical devices for the treatment of heart and vascular diseases in France. It develops Kardiozis technology for the treatment of abdominal aortic aneurysm; Kalios and Epygon implants to treat mitral insufficiency; and Artus implant, an implantable electro-mechanical artificial sphincter for the treatment of severe urinary incontinence in women and men. The company was founded in 2011 and is based in Aix-en-Provence, France.

CAC 40 ended the session with AFFLUENT MEDICAL rising 15.22% to €2.12 on Friday, after five consecutive sessions in a row of gains. CAC 40 fell 0.03% to €7,568.82, following the last session’s downward trend on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, AFFLUENT MEDICAL has a trailing twelve months EPS of €-0.65.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -39.36%.

More news about AFFLUENT MEDICAL.

4. BELYSSE GROUP (BELYS.BR)

11.78% Price Change

Belysse Group NV produces and sells textile floor coverings for commercial and residential applications in Europe, North America, and internationally. The company designs, manufactures, and distributes broadloom carpets and modular carpet tiles primarily for offices and public projects. It commercializes its products under the Bentley, modulyss, arc edition, and ITC brands. The company was formerly known as Balta Group NV and changed its name to Belysse Group NV in October 2022. Belysse Group NV was founded in 1964 and is headquartered in Waregem, Belgium. Belysse Group NV is a subsidiary of LSF9 Belysse Holdco S.à r.l.

BEL 20 ended the session with BELYSSE GROUP jumping 11.78% to €0.74 on Friday while BEL 20 rose 1.66% to €3,679.69.

Earnings Per Share

As for profitability, BELYSSE GROUP has a trailing twelve months EPS of €-0.45.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BELYSSE GROUP’s stock is considered to be overbought (>=80).

More news about BELYSSE GROUP.

5. NEXITY (NXI.PA)

11.07% Price Change

Nexity SA operates as a real estate company in Europe and internationally. The company operates through Development, Services, and Other Activities divisions. It develops new homes and subdivisions; and new or refurbished office buildings, high-rises building, business parks, logistics facilities, retail property, hotels, and other industrial spaces. The company also provides property management services comprising rental management, sales and lettings, and condominium managing agent services, as well as manages serviced residences for students; distributes real estate products under the iSelection and PERL brands; offers insurance brokerage and asset management services; and real estate services, including rental management and property management services, consulting, and short-term rental of working spaces. In addition, it engages in the villes and projets, and pre-development urban regeneration projects; and investment activities. The company serves individual, corporate, institutional, and local authority clients. Nexity SA was founded in 1995 and is headquartered in Paris, France.

CAC 40 ended the session with NEXITY rising 11.07% to €17.26 on Friday, after four consecutive sessions in a row of gains. CAC 40 slid 0.03% to €7,568.82, following the last session’s downward trend on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, NEXITY has a trailing twelve months EPS of €2.26.

PE Ratio

NEXITY has a trailing twelve months price to earnings ratio of 7.64. Meaning, the purchaser of the share is investing €7.64 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.59%.

Moving Average

NEXITY’s value is way above its 50-day moving average of €13.80 and below its 200-day moving average of €17.69.

More news about NEXITY.

6. MOLTEN VENTURES (GRW.IR)

10.2% Price Change

Molten Ventures Plc, formerly known as Draper Esprit plc, is a private equity and venture capital firm specializing in any stage in the lifecycle of a business from seed and series A stage, growth capital to pre-IPO investments, late stage, start-ups, cross-stage investments, buyouts, PIPES, and also makes direct and secondary investments in portfolio companies. It also seeks to buy entire funds from other tech investors. The firm primarily invests in companies from pre-revenue stage upwards. It primarily invests in technology oriented business. The firm typically invests in digital technology, consumer, commerce, enterprise and data, systems and semiconductors, financial technology, internet, mobile, media, telecom, consumer technology, enterprise technology, SaaS, fintech, deeptech, digital health & wellness and healthcare sectors, prop tech, software, hardware, medical technology, and life sciences sectors. It invests in companies based in Europe, United states, Austria, Belgium, Denmark, Germany, Finland, France, Netherlands, Poland, Romania, Spain, Sweden, Switzerland, Ireland, and United Kingdom. The firm seeks to invest between $0.02 million and €10 million ($10.88 million) in rounds up to €1 million ($1.09 million) and €30 million ($32.63 million). It invests 30 percent of its corpus in very early stage companies with less than $5 million in revenues. The firm seeks to make minority and majority investments. Molten Ventures Plc was founded in 1984 and is based in London, United Kingdom with an additional offices in Dublin, Ireland.

ISEQ All Share ended the session with MOLTEN VENTURES rising 10.2% to €3.24 on Friday, after five consecutive sessions in a row of losses. ISEQ All Share rose 0.5% to €8,798.37, following the last session’s downward trend on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, MOLTEN VENTURES has a trailing twelve months EPS of €-1.2.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -18.52%.

More news about MOLTEN VENTURES.

7. PIERRE VAC BSA ACT (VACBS.PA)

8.68% Price Change

CAC 40 ended the session with PIERRE VAC BSA ACT jumping 8.68% to €0.17 on Friday while CAC 40 dropped 0.03% to €7,568.82.

Yearly Top and Bottom Value

PIERRE VAC BSA ACT’s stock is valued at €0.17 at 21:40 EST, way below its 52-week low of €0.15.

More news about PIERRE VAC BSA ACT.

8. OCEANTEAM (OTS.OL)

8.53% Price Change

Oceanteam ASA operates as a subsea and offshore services company in Europe. It provides equipment for offshore cable laying, umbilical installations, and on- and offshore storage and transport. The company also rents turntables, tensioners, reels, demountable turntable systems, and other cable handling and storage equipment, as well as offers cable and umbilical storage, and handling solutions. It serves renewable energy, and oil and gas industries. The company was formerly known as Oceanteam Shipping ASA and changed its name to Oceanteam ASA in December 2015. Oceanteam ASA was incorporated in 2005 and is headquartered in Bærum, Norway.

Oslo Børs Benchmark Index_GI ended the session with OCEANTEAM rising 8.53% to €1.40 on Friday while Oslo Børs Benchmark Index_GI jumped 0.22% to €1,295.42.

Earnings Per Share

As for profitability, OCEANTEAM has a trailing twelve months EPS of kr-0.3.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -13.62%.

Volume

Today’s last reported volume for OCEANTEAM is 152245 which is 434.92% above its average volume of 28461.

Yearly Top and Bottom Value

OCEANTEAM’s stock is valued at kr1.40 at 21:40 EST, way under its 52-week high of kr2.01 and way above its 52-week low of kr1.10.

Moving Average

OCEANTEAM’s worth is under its 50-day moving average of kr1.43 and below its 200-day moving average of kr1.55.

More news about OCEANTEAM.

9. ARGENX SE (ARGX.BR)

7.33% Price Change

argenx SE, a biotechnology company, engages in the developing of various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany, France, Canada, the United Kingdom, and Italy. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, pemphigus foliaceus, chronic inflammatory demyelinating polyneuropathy, bullous pemphigoid, and idiopathic inflammatory myopathy; and ENHANZE SC. The company is also developing ARGX-109 and ARGX-116; ARGX-117 for severe autoimmune indications; ARGX-118 for airway inflammation; ARGX-119, an antibody that targets muscle-specific tyrosine kinase stage; and ARGX-114, an antibody directed against the mesenchymal-epithelial transition factor receptor. In addition, its partnered product candidates include Cusatuzumab for treatment of acute myeloid leukemia; ARGX-115 for the treatment of cancer; and ARGX-112 to treat interleukin-22 receptor. The company has strategic partnership with AbbVie S.À.R.L., Zai Lab Limited, and LEO Pharma A/S; and collaboration and license agreement with Genor Biopharma Co. Ltd, Université Catholique de Louvain, Sopartec S.A., NYU Langone Health, Leiden University Medical Center, AgomAb Therapeutics NV, Broteio Pharma B.V., VIB vzw, University of Texas, BioWa, Inc., Staten Biotechnology B.V., and Shire International GmbH. It also has collaboration agreement with Genmab A/S to discover, develop, and commercialize novel therapeutic antibodies with applications in immunology and oncology, as well as a strategic collaboration with IQVIA Holdings Inc. to provide safety systems and services. argenx SE was incorporated in 2008 and is based in Amsterdam, the Netherlands.

BEL 20 ended the session with ARGENX SE jumping 7.33% to €320.60 on Friday, after five consecutive sessions in a row of losses. BEL 20 rose 1.66% to €3,679.69, after two sequential sessions in a row of losses, on what was an all-around up trend exchanging session today.

Earnings Per Share

As for profitability, ARGENX SE has a trailing twelve months EPS of €-3.76.

Volatility

ARGENX SE’s last week, last month’s, and last quarter’s current intraday variation average was a negative 9.98%, a negative 2.20%, and a positive 1.94%.

ARGENX SE’s highest amplitude of average volatility was 9.98% (last week), 3.30% (last month), and 1.94% (last quarter).

More news about ARGENX SE.

10. HYLORIS (HYL.BR)

7.27% Price Change

Hyloris Pharmaceuticals SA engages in the develop, manufacture, and deliver pharmaceutical products to address unmet medical needs in cardiovascular health and other major therapeutic areas. It offers cardiovascular products for atrial fibrillation, acute coronary syndrome, advanced heart failure, congestive heart failure, acute coronary syndrome, and coronary heart disease. The company provides Maxigesic IV, a combination of paracetamol and ibuprofen used for post-operative non-opioid pain management; Tranexamic acid RTU, an antifibrinolytic drug for the formation of blood clots; Miconazole/Domiphen Bromide, a topical synergistic combination treatment for Recurrent Vulvovaginal Candidiasis; AlenuraTM, a first-line drug treatment for acute pain in interstitial cystitis/bladder pain syndrome; and Plecoid Agent IV for the treatment of acute myeloid leukemia and small cell lung cancer. It also offers Atomoxetine, an oral liquid for the treatment of patients with attention deficit hyperactivity disorder; HY-029, a liquid formulation of an antiviral drug to treat viral infections; HY-083, a nasal spray for the treatment of idiopathic rhinitis; and HY-088, an oral liquid that treats hypophosphatemia. The company was incorporated in 2012 and is headquartered in Liège, Belgium.

BEL 20 ended the session with HYLORIS jumping 7.27% to €11.80 on Friday while BEL 20 rose 1.66% to €3,679.69.

Earnings Per Share

As for profitability, HYLORIS has a trailing twelve months EPS of €-0.46.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -22.8%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 12.3%, now sitting on 3.08M for the twelve trailing months.

Volume

Today’s last reported volume for HYLORIS is 11323 which is 34.95% above its average volume of 8390.

Moving Average

HYLORIS’s value is below its 50-day moving average of €12.40 and under its 200-day moving average of €12.09.

More news about HYLORIS.

Losers Today

1. PROSUS (PRX.AS)

-17.1% Price Change

Prosus N.V. engages in the e-commerce and internet businesses. The company operates internet platforms, such as classifieds, payments and fintech, food delivery, education technology, etail, health, ventures, social, and other internet platforms. It has operations in Latin and North America, the Middle East, Africa, Europe, Asia, and internationally. The company was formerly known as Myriad International Holdings N.V. and changed its name to Prosus N.V. in August 2019. Prosus N.V. was incorporated in 1994 and is headquartered in Amsterdam, the Netherlands. Prosus N.V. operates as a subsidiary of Naspers Limited.

AEX-Index ended the session with PROSUS falling 17.1% to €24.53 on Friday, after two successive sessions in a row of losses. AEX-Index slid 0.56% to €785.45, following the last session’s downward trend on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, PROSUS has a trailing twelve months EPS of €3.34.

PE Ratio

PROSUS has a trailing twelve months price to earnings ratio of 7.34. Meaning, the purchaser of the share is investing €7.34 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.98%.

Yearly Top and Bottom Value

PROSUS’s stock is valued at €24.53 at 21:40 EST, under its 52-week low of €25.49.

Revenue Growth

Year-on-year quarterly revenue growth grew by 12.6%, now sitting on 6.05B for the twelve trailing months.

Volatility

PROSUS’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.70%, a negative 0.11%, and a positive 1.34%.

PROSUS’s highest amplitude of average volatility was 2.22% (last week), 0.95% (last month), and 1.34% (last quarter).

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Nov 2, 2023, the estimated forward annual dividend rate is 0.07 and the estimated forward annual dividend yield is 0.23%.

More news about PROSUS.

2. NORTHERN DRILLING (NODL.OL)

-10.86% Price Change

Northern Drilling Ltd. operates as an offshore drilling contractor to the oil and gas industry. The company primarily engages in acquiring and operating offshore drilling assets, as well as involved in drilling in ultra-deep water environments. Northern Drilling Ltd. was incorporated in 2017 and is based in Hamilton, Bermuda.

Oslo Børs Benchmark Index_GI ended the session with NORTHERN DRILLING sliding 10.86% to €1.19 on Friday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI rose 0.22% to €1,295.42, after three consecutive sessions in a row of losses, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, NORTHERN DRILLING has a trailing twelve months EPS of kr-5.75.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.22%.

Volatility

NORTHERN DRILLING’s last week, last month’s, and last quarter’s current intraday variation average was a positive 14.16%, a negative 1.33%, and a positive 14.70%.

NORTHERN DRILLING’s highest amplitude of average volatility was 19.08% (last week), 23.82% (last month), and 14.70% (last quarter).

Yearly Top and Bottom Value

NORTHERN DRILLING’s stock is valued at kr1.19 at 21:40 EST, way below its 52-week high of kr34.90 and way higher than its 52-week low of kr0.31.

More news about NORTHERN DRILLING.

3. SOC FRANC CASINOS (SFCA.PA)

-10.16% Price Change

Société Française de Casinos Société Anonyme operates casinos in France. The company is also involved in the hotel and restaurant activities. The company was incorporated in 1993 and is based in Paris, France.

CAC 40 ended the session with SOC FRANC CASINOS sliding 10.16% to €1.68 on Friday while CAC 40 dropped 0.03% to €7,568.82.

Earnings Per Share

As for profitability, SOC FRANC CASINOS has a trailing twelve months EPS of €0.31.

PE Ratio

SOC FRANC CASINOS has a trailing twelve months price to earnings ratio of 5.42. Meaning, the purchaser of the share is investing €5.42 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.87%.

Volatility

SOC FRANC CASINOS’s last week, last month’s, and last quarter’s current intraday variation average was 3.68%, 0.67%, and 4.05%.

SOC FRANC CASINOS’s highest amplitude of average volatility was 3.68% (last week), 3.26% (last month), and 4.05% (last quarter).

Yearly Top and Bottom Value

SOC FRANC CASINOS’s stock is valued at €1.68 at 21:40 EST, way below its 52-week high of €2.12 and way higher than its 52-week low of €1.48.

More news about SOC FRANC CASINOS.

4. HOSTELWORLD GROUP (HSW.IR)

-8.64% Price Change

Hostelworld Group plc operates an online booking platform worldwide. The company offers software and data processing services that facilitate hostel, B&B, hotel, and other accommodation bookings. The company also provides business information consulting and marketing planning services; and marketing, and research and development services. In addition, it is engaged in technology trading business. Hostelworld Group plc was founded in 1999 and is based in Dublin, Ireland.

ISEQ All Share ended the session with HOSTELWORLD GROUP dropping 8.64% to €1.48 on Friday while ISEQ All Share rose 0.5% to €8,798.37.

Earnings Per Share

As for profitability, HOSTELWORLD GROUP has a trailing twelve months EPS of €-0.09.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -21.01%.

Volume

Today’s last reported volume for HOSTELWORLD GROUP is 1 which is 99.89% below its average volume of 935.

Revenue Growth

Year-on-year quarterly revenue growth grew by 64%, now sitting on 87.57M for the twelve trailing months.

More news about HOSTELWORLD GROUP.

5. GROUPE SFPI (SFPI.PA)

-8.45% Price Change

GROUPE SFPI SA designs, manufactures, and markets equipment for the safety industry in Europe and internationally. The company operates through DOM Security, NEU-JKF, MMD, MAC, and Other divisions. It offers closure equipment, such as windows and joinery, shutters and blinds, entrance and garage doors, industrial closures, carpentry, and awnings for building industry under the France Fermetures, Franciaflex, Faber, SIPA Menuiseries, and Wo&Wo brands. The company also provides access and locking solutions for buildings, homeowners, small businesses, and large companies. In addition, it offers air treatment solutions, such as dust removal systems, air filtration and conditioning equipment, pneumatic treatment equipment for production waste, pneumatic transport equipment, industrial fans, etc. Further, the company provides thermal processing and sterilization solutions. GROUPE SFPI SA was founded in 1985 and is headquartered in Paris, France.

CAC 40 ended the session with GROUPE SFPI dropping 8.45% to €1.95 on Friday while CAC 40 fell 0.03% to €7,568.82.

Earnings Per Share

As for profitability, GROUPE SFPI has a trailing twelve months EPS of €0.19.

PE Ratio

GROUPE SFPI has a trailing twelve months price to earnings ratio of 10.26. Meaning, the purchaser of the share is investing €10.26 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.95%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, GROUPE SFPI’s stock is considered to be oversold (<=20).

More news about GROUPE SFPI.

6. BYGGMA (BMA.OL)

-6.05% Price Change

Byggma ASA manufactures and supplies building materials in Norway, Sweden, Denmark, Finland, the United Kingdom, the Netherlands, and internationally. It offers pre-painted ceilings and wall panels under the Huntonit brand name; I-beams for use in ceilings, walls, and floors for wood-based buildings under the brand name of Masonite; and particle boards, boards, and structural panels for use in buildings, interior ceilings, and wall panels under the Forestia brand name. The company also provides doors and windows for new buildings, extensions, and rehabilitation under the brand name of Uldal; a range of decorative home and lighting products, and lampshades under the Aneta brand name; and develops, manufactures, and distributes MDF panels for walls, ceilings, bathrooms, and kitchens under the brand name of Smartpanel, as well as supplies chipboard, OSB, and plywood boards. It exports its products. Byggma ASA was incorporated in 1997 and is headquartered in Vennesla, Norway. Byggma ASA operates as a subsidiary of Investor As.

Oslo Børs Benchmark Index_GI ended the session with BYGGMA dropping 6.05% to €20.20 on Friday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI rose 0.22% to €1,295.42, after three sequential sessions in a row of losses, on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, BYGGMA has a trailing twelve months EPS of kr2.05.

PE Ratio

BYGGMA has a trailing twelve months price to earnings ratio of 9.85. Meaning, the purchaser of the share is investing kr9.85 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.78%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

BYGGMA’s EBITDA is 31.03.

More news about BYGGMA.

7. SEQUANA MEDICAL (SEQUA.BR)

-5.61% Price Change

Sequana Medical NV develops and commercializes treatment of fluid overload in liver disease, cancer, and heart failure. The company's products include alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; Direct Sodium Removal (DSR) for the treatment of persistent congestion due to heart failure; and alfapump DSR, a fully implanted system for direct sodium removal therapy in patients with fluid overload due to heart failure. It operates in Belgium, Germany, France, Switzerland, and internationally. The company was founded in 2006 and is headquartered in Ghent, Belgium.

BEL 20 ended the session with SEQUANA MEDICAL falling 5.61% to €3.70 on Friday, following the last session’s downward trend. BEL 20 rose 1.66% to €3,679.69, after two sequential sessions in a row of losses, on what was an all-around bullish trend exchanging session today.

Earnings Per Share

As for profitability, SEQUANA MEDICAL has a trailing twelve months EPS of €-1.32.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -690.43%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 17.3%, now sitting on 842.41k for the twelve trailing months.

More news about SEQUANA MEDICAL.

8. ATEME (ATEME.PA)

-5.22% Price Change

ATEME SA, together with its subsidiaries, provides electronic and computer devices and instruments worldwide. The company offers various solutions, such as TITAN Live, a software-based live video compression for the converged headend; TITAN File, a video transcoding software; TITAN Mux, a multi-function software stream processing solution; KYRION CM5000e, an ultra-low latency encoder; TITAN Edge encoder; TITAN Edge decoder; TITAN Edge gateway; and KYRION DR5000, an ultra-low latency integrated receiver decoder. It also provides NEA-CDN, an OTT scale service solution; NEA-DVR; NEA-Live for immersive viewing experience; NEA-Composer, a dynamic Ad insertion and linear origination solution; PILOT Media, a cloud native media supply chain solution; and PILOT Manager, a cloud native management system. The company serves content providers, service providers, and streaming platforms. ATEME SA was incorporated in 1991 and is headquartered in Vélizy-Villacoublay, France.

CAC 40 ended the session with ATEME falling 5.22% to €6.54 on Friday, after two sequential sessions in a row of gains. CAC 40 slid 0.03% to €7,568.82, following the last session’s downward trend on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, ATEME has a trailing twelve months EPS of €-0.28.

Volatility

ATEME’s last week, last month’s, and last quarter’s current intraday variation average was 3.04%, 0.26%, and 1.98%.

ATEME’s highest amplitude of average volatility was 3.04% (last week), 2.13% (last month), and 1.98% (last quarter).

Volume

Today’s last reported volume for ATEME is 6427 which is 98.54% above its average volume of 3237.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ATEME’s stock is considered to be oversold (<=20).

More news about ATEME.

9. ATENOR (ATEB.BR)

-4.62% Price Change

Atenor SA, a real estate development company, invests in large-scale real estate projects in Belgium, Luxembourg, the Netherlands, France, Germany, Portugal, Poland, Hungary, the United Kingdom, and Romania. The company develops real estate projects, such as offices and residential buildings. Atenor SA was founded in 1910 and is headquartered in La Hulpe, Belgium.

BEL 20 ended the session with ATENOR falling 4.62% to €6.20 on Friday, after five consecutive sessions in a row of gains. BEL 20 rose 1.66% to €3,679.69, after two consecutive sessions in a row of losses, on what was an all-around up trend trading session today.

Earnings Per Share

As for profitability, ATENOR has a trailing twelve months EPS of €-5.33.

Volatility

ATENOR’s last week, last month’s, and last quarter’s current intraday variation average was 2.04%, 0.59%, and 5.57%.

ATENOR’s highest amplitude of average volatility was 2.04% (last week), 3.73% (last month), and 5.57% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ATENOR’s stock is considered to be oversold (<=20).

Volume

Today’s last reported volume for ATENOR is 39163 which is 16.37% below its average volume of 46834.

More news about ATENOR.

10. SALMAR (SALM.OL)

-4.57% Price Change

SalMar ASA, an aquaculture company, produces and sells farmed salmon in Asia, North America, Europe, and internationally. The company operates through Fish Farming, Sales & Industry, Icelandic Salmon, and SalMar Aker Ocean segments. It is involved in the broodstock, lumpfish, and smolt production activities; and marine-phase farming, harvesting, processing, and selling farmed salmon. SalMar ASA was founded in 1991 and is headquartered in Kverva, Norway.

Oslo Børs Benchmark Index_GI ended the session with SALMAR dropping 4.57% to €530.60 on Friday, after two sequential sessions in a row of losses. Oslo Børs Benchmark Index_GI rose 0.22% to €1,295.42, after three consecutive sessions in a row of losses, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, SALMAR has a trailing twelve months EPS of kr6.56.

PE Ratio

SALMAR has a trailing twelve months price to earnings ratio of 80.88. Meaning, the purchaser of the share is investing kr80.88 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.83%.

Moving Average

SALMAR’s worth is under its 50-day moving average of kr557.76 and above its 200-day moving average of kr490.95.

Volume

Today’s last reported volume for SALMAR is 243682 which is 33.98% above its average volume of 181873.

Yearly Top and Bottom Value

SALMAR’s stock is valued at kr530.60 at 21:40 EST, way under its 52-week high of kr598.80 and way above its 52-week low of kr354.20.

Volatility

SALMAR’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.44%, a negative 0.27%, and a positive 1.17%.

SALMAR’s highest amplitude of average volatility was 0.90% (last week), 0.75% (last month), and 1.17% (last quarter).

More news about SALMAR.

Stay up to date with our winners and losers daily report